Literature DB >> 3916029

Methods for detecting pulmonary edema.

L W Hedlund, C E Putman.   

Abstract

Pulmonary edema appears to develop in three phases: after an initial injury to the lung, permeability of the air-blood barrier to water increases; a subsequent increase in movement of extra-vascular fluid; and finally, there is a significant increase in extravascular fluid volume (interstitial and alveolar). Ideally, early detection should monitor the initial phases of pulmonary edema, namely, the injury and the increased permeability. All established clinical and most of the research methods, however, monitor only the final or volume phase of the edema process. The chest radiograph is perhaps the most commonly used method for clinical detection of pulmonary edema, although it lacks the sensitivity for assessment of edema much before clinical signs are apparent. This paper reviews some of the clinical and research methods for detecting pulmonary edema with special emphasis on radiographic methods.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3916029     DOI: 10.1177/074823378500100206

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  2 in total

Review 1.  Acute lung injury after phosgene inhalation.

Authors:  S C Lim; J Y Yang; A S Jang; Y U Park; Y C Kim; I S Choi; K O Park
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

2.  The 2021 SIIM-FISABIO-RSNA Machine Learning COVID-19 Challenge: Annotation and Standard Exam Classification of COVID-19 Chest Radiographs.

Authors:  Paras Lakhani; J Mongan; C Singhal; Q Zhou; K P Andriole; W F Auffermann; P M Prasanna; T X Pham; Michael Peterson; P J Bergquist; T S Cook; S F Ferraciolli; G C A Corradi; M S Takahashi; C S Workman; M Parekh; S I Kamel; J Galant; A Mas-Sanchez; E C Benítez; M Sánchez-Valverde; L Jaques; M Panadero; M Vidal; M Culiañez-Casas; D Angulo-Gonzalez; S G Langer; María de la Iglesia-Vayá; G Shih
Journal:  J Digit Imaging       Date:  2022-09-28       Impact factor: 4.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.